CervoMed (CRVO) Competitors $2.11 0.00 (0.00%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends CRVO vs. OPTN, ELEV, DYAI, ACHL, IVVD, ICCC, CELU, XLO, KZR, and VYNEShould you be buying CervoMed stock or one of its competitors? The main competitors of CervoMed include OptiNose (OPTN), Elevation Oncology (ELEV), Dyadic International (DYAI), Achilles Therapeutics (ACHL), Invivyd (IVVD), ImmuCell (ICCC), Celularity (CELU), Xilio Therapeutics (XLO), Kezar Life Sciences (KZR), and VYNE Therapeutics (VYNE). These companies are all part of the "pharmaceutical products" industry. CervoMed vs. OptiNose Elevation Oncology Dyadic International Achilles Therapeutics Invivyd ImmuCell Celularity Xilio Therapeutics Kezar Life Sciences VYNE Therapeutics CervoMed (NASDAQ:CRVO) and OptiNose (NASDAQ:OPTN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and community ranking. Does the media refer more to CRVO or OPTN? In the previous week, OptiNose had 9 more articles in the media than CervoMed. MarketBeat recorded 10 mentions for OptiNose and 1 mentions for CervoMed. CervoMed's average media sentiment score of 1.00 beat OptiNose's score of 0.00 indicating that CervoMed is being referred to more favorably in the media. Company Overall Sentiment CervoMed Positive OptiNose Neutral Which has higher earnings and valuation, CRVO or OPTN? CervoMed has higher earnings, but lower revenue than OptiNose. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCervoMed$7.14M1.82-$2.17MN/AN/AOptiNose$70.99M0.90-$35.48M-$4.20-1.52 Do analysts recommend CRVO or OPTN? CervoMed presently has a consensus target price of $42.00, suggesting a potential upside of 1,890.52%. OptiNose has a consensus target price of $16.67, suggesting a potential upside of 161.23%. Given CervoMed's higher possible upside, equities analysts clearly believe CervoMed is more favorable than OptiNose.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CervoMed 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.44OptiNose 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is CRVO or OPTN more profitable? OptiNose has a net margin of -41.16% compared to CervoMed's net margin of -118.68%. OptiNose's return on equity of 0.00% beat CervoMed's return on equity.Company Net Margins Return on Equity Return on Assets CervoMed-118.68% -44.11% -39.81% OptiNose -41.16%N/A -27.42% Do insiders & institutionals believe in CRVO or OPTN? 25.2% of CervoMed shares are owned by institutional investors. Comparatively, 85.6% of OptiNose shares are owned by institutional investors. 36.3% of CervoMed shares are owned by company insiders. Comparatively, 2.3% of OptiNose shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more volatility & risk, CRVO or OPTN? CervoMed has a beta of 1.78, indicating that its share price is 78% more volatile than the S&P 500. Comparatively, OptiNose has a beta of -0.15, indicating that its share price is 115% less volatile than the S&P 500. Does the MarketBeat Community prefer CRVO or OPTN? OptiNose received 236 more outperform votes than CervoMed when rated by MarketBeat users. However, 72.22% of users gave CervoMed an outperform vote while only 63.68% of users gave OptiNose an outperform vote. CompanyUnderperformOutperformCervoMedOutperform Votes1372.22% Underperform Votes527.78% OptiNoseOutperform Votes24963.68% Underperform Votes14236.32% SummaryCervoMed and OptiNose tied by winning 8 of the 16 factors compared between the two stocks. Get CervoMed News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRVO vs. The Competition Export to ExcelMetricCervoMedPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.02M$6.34B$5.21B$8.93BDividend YieldN/A2.94%5.13%4.04%P/E RatioN/A9.8989.8017.35Price / Sales1.82315.771,248.2377.32Price / CashN/A61.4443.8235.97Price / Book1.626.055.324.79Net Income-$2.17M$154.90M$122.69M$225.00M7 Day PerformanceN/A-1.70%-0.17%1.52%1 Month Performance-5.38%1.93%3.49%4.88%1 Year Performance-77.31%3.14%25.79%20.12% CervoMed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRVOCervoMed3.6068 of 5 stars$2.11flat$42.00+1,890.5%-76.8%$13.02M$7.14M0.004Short Interest ↓Positive NewsOPTNOptiNose4.3819 of 5 stars$5.02-5.3%$26.00+417.9%-67.5%$50.50M$75.67M-17.93190Analyst ForecastNews CoverageGap UpELEVElevation Oncology2.4029 of 5 stars$0.83+27.2%$7.20+770.6%-74.0%$48.89MN/A-1.0140Analyst ForecastAnalyst RevisionNews CoverageGap UpHigh Trading VolumeDYAIDyadic International3.1471 of 5 stars$1.64-0.6%$6.00+265.9%-3.2%$48.53M$3.36M-7.137Short Interest ↓Positive NewsGap UpACHLAchilles Therapeutics2.6853 of 5 stars$1.17-1.3%$4.00+241.9%+35.9%$48.09MN/A-0.71250Short Interest ↑News CoveragePositive NewsIVVDInvivyd3.0907 of 5 stars$0.40-11.4%$7.89+1,868.9%-90.8%$47.92M$11.56M-0.20100Short Interest ↑ICCCImmuCell0.1061 of 5 stars$5.36+3.3%N/A-2.0%$47.77M$23.84M-10.7270Short Interest ↑News CoverageCELUCelularity0.4659 of 5 stars$2.15-0.5%N/A-20.4%$47.27M$48.20M0.00220Short Interest ↑Negative NewsGap DownXLOXilio Therapeutics3.1757 of 5 stars$1.07-2.7%$4.00+273.8%+65.8%$47.04M$4.62M-0.6270Short Interest ↑Positive NewsKZRKezar Life Sciences3.9198 of 5 stars$6.41-1.5%$39.50+516.2%-26.3%$46.77M$7M-0.4960Short Interest ↑News CoverageVYNEVYNE Therapeutics3.7994 of 5 stars$3.15-8.2%$6.88+118.3%+44.4%$46.47M$493,000.00-3.6630Analyst ForecastGap Up Related Companies and Tools Related Companies OPTN Alternatives ELEV Alternatives DYAI Alternatives ACHL Alternatives IVVD Alternatives ICCC Alternatives CELU Alternatives XLO Alternatives KZR Alternatives VYNE Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CRVO) was last updated on 1/19/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CervoMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CervoMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
